Net Loss per Share (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2016

Dec. 31, 2015

Net Loss Per Share Tables

Potentially dilutive securities

	As of June 30,
	2016		2015
Stock options		632,310		384,195
Restricted stock awards		212,689		294,709
Preferred stock		2,792,190		3,128,108
Common stock warrants		1,199,505		805,361
Total		4,836,694		4,612,373

	Years Ended December 31,
	2015		2014
Stock options		438,248		6,030
MabVax Series A redeemable convertible preferred stock		—		18,596
MabVax Series B redeemable convertible preferred stock		—		21,114
MabVax Series C-1 redeemable convertible preferred stock		—		55,736
Series B redeemable convertible preferred stock		—		13,905
Series A-1 preferred stock		—		100,359
Series C preferred stock		—		6,355
Series D preferred stock		2,587,717		—
Series E preferred stock		450,446		—
Unvested restricted stock		310,926		—
Warrants to purchase common stock		974,280		—
Total		4,761,617		222,095